ArticlePediatric blood & cancer2019

Evaluation of entinostat alone and in combination with standard-of-care cytotoxic agents against rhabdomyosarcoma xenograft models.

Raushan T Kurmasheva et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.